Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit
Open Access
- 22 July 2014
- journal article
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 2 (1) , e000037
Abstract
Background Maintaining glucose in the target range, while avoiding hypoglycemia, is challenging in critically ill patients. We investigated the performance and safety of Medtronic Sentrino, a newly developed continuous glucose management (CGM) system for critically ill adults. Methods This was a prospective, single-center, single-arm, open-label study in adult patients with cardiac ICU admission. Sentrino subcutaneous glucose sensors were inserted into patients’ thigh with planned study participation of 72 h. Sensor glucose results were displayed, and the system's alerts and alarms fully enabled. Reference blood glucose was collected from central venous catheter and analyzed with a blood gas analyzer. Treatment decisions were made independently of sensor glucose values, according to the existing standard of care. Results A total of 21 patients were enrolled; all successfully completed the study. Sensor glucose values were displayed 96% of the time, and 870 paired blood glucose–sensor glucose points were analyzed. Overall mean absolute relative difference (MARD) was 12.8% (95% CI 11.9% to 13.6%). No clinically significant differences in accuracy were seen within subgroups of hemodynamic status (MARD 12.3% and 13.1% for compromised vs stable hemodynamics). Consensus grid analysis showed >99% of sensor glucose values within A/B zones. No device or study-related adverse events were reported. 100% of clinicians found Sentrino easy to use after two patients. Conclusions In our single-center experience, Sentrino CGM system demonstrated good accuracy and reliability, with no device-related adverse events in critically ill cardiac patients, and was easy to use and integrate in the cardiac ICU. Trial registration number NCT01763567.Keywords
This publication has 12 references indexed in Scilit:
- Microcirculation and its relation to continuous subcutaneous glucose sensor accuracy in cardiac surgery patients in the intensive care unitThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Clinical review: Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adultsCritical Care, 2013
- Accuracy and Reliability of Continuous Glucose Monitoring in the Intensive Care Unit: A Head-to-Head Comparison of Two Subcutaneous Glucose Sensors in Cardiac Surgery PatientsDiabetes Care, 2011
- Real-Time Continuous Glucose Monitoring in Critically Ill PatientsDiabetes Care, 2009
- Numerical and Clinical Accuracy of a Continuous Glucose Monitoring System during Intravenous Insulin Therapy in the Surgical and Burn Intensive Care UnitsJournal of Diabetes Science and Technology, 2009
- The Society of Thoracic Surgeons Practice Guideline Series: Blood Glucose Management During Adult Cardiac SurgeryThe Annals of Thoracic Surgery, 2009
- Pre- and Postoperative Accuracy and Safety of a Real-Time Continuous Glucose Monitoring System in Cardiac Surgical Patients: A Randomized Pilot StudyDiabetes Technology & Therapeutics, 2009
- Hyperglycemia and Acute Coronary SyndromeAnesthesiology, 2008
- Effect of Hyperglycemia and Continuous Intravenous Insulin Infusions on Outcomes of Cardiac Surgical Procedures: The Portland Diabetic ProjectEndocrine Practice, 2004
- Implementation of a Safe and Effective Insulin Infusion Protocol in a Medical Intensive Care UnitDiabetes Care, 2004